P

Inventor

PANKNIN OLAF

DE17 patents
⚠️ This page may combine multiple inventors who share the name “PANKNIN OLAF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

Bayer Pharma AG

16 patents
US9957235B2May 1, 2018

Benzimidazol-2-amines as mIDH1 inhibitors

Bayer Pharma AG8 citations83
US9951027B2Apr 24, 2018

Benzimidazol-2-amines as MIDH1 inhibitors

Bayer Pharma AG8 citations83
US12478696B2Nov 25, 2025

Gadolinium chelate compounds for use in magnetic resonance imaging

Bayer Pharma AG1 citations74
US11491245B2Nov 8, 2022

Gadolinium chelate compounds for use in magnetic resonance imaging

Bayer Pharma AG2 citations72
US10722601B2Jul 28, 2020

Gadolinium chelate compounds for use in magnetic resonance imaging

Bayer Pharma AG2 citations72
US10370339B2Aug 6, 2019

N-Methylbenzimidazoles as mIDH1 inhibitors

Bayer Pharma AG2 citations72
US10179123B2Jan 15, 2019

2-aryl- and 2-arylalkyl-benzimidazoles as mIDH1 inhibitors

Bayer Pharma AG4 citations72
US10137209B2Nov 27, 2018

Gadolinium chelate compounds for use in magnetic resonance imaging

Bayer Pharma AG2 citations72
US10137110B2Nov 27, 2018

1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors

Bayer Pharma AG4 citations70
US10414734B2Sep 17, 2019

5-hydroxyalkylbenzimidazoles as mIDH1 inhibitors

Bayer Pharma AG1 citations62
US11814369B2Nov 14, 2023

High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging

Bayer Pharma AG0 citations61
US10975060B2Apr 13, 2021

High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging

Bayer Pharma AG1 citations61
US11427578B1Aug 30, 2022

Substituted pyrrolopyridine-derivatives

Bayer Pharma AG1 citations55
US10442772B2Oct 15, 2019

Benzimidazol-2-amines as mIDH1 inhibitors

Bayer Pharma AG0 citations51
US10919862B2Feb 16, 2021

Fused imidazoles as mIDH1 inhibitors

Bayer Pharma AG0 citations49
US11311520B2Apr 26, 2022

Substituted dihydroimidazopyridinediones as MKNK1 and MKNK2 inhibitors

Bayer Pharma AG0 citations45

BAYER AG

1 patent